π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
In the Netherlands a 2 center investigator-driven phase I/II clinical trial...
Status
Completed
Location
ERasmus Medical Center
Start Date
2010-06
Trial ID
NCT01582516
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
The use of chemoradiotherapy (CRT), in combination with surgery is the stan...
Status
Completed
Location
Velindre Cancer Centre
Start Date
2019-07-29
Trial ID
NCT03916510
Treatments Being Tested
The study is aimed at assessing the safety and immunogenicity of HCV prime-...
Status
Completed
Location
Centre for Cinical Vaccinology and Tropical Medicine, Univeristy of Oxford
Start Date
2017-12-04
Trial ID
NCT03688061
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Honor Health Research Institute
Start Date
2019-07-02
Trial ID
NCT03989115
Treatments Being Tested
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
In this study, patients with relapsed or refractory ovarian cancer will rec...
Status
Terminated
Location
Florida Cancer Specialists
Start Date
2010-01
Trial ID
NCT01035658
Assessment of effectiveness, safety and local immune activation of Oncolyti...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-03-05
Trial ID
NCT04771676
Treatments Being Tested
This will be a randomized single-blind controlled trial to determine the im...
Status
Completed
Location
Hospital Ampang
Start Date
2022-09-20
Trial ID
NCT05517642
This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Status
Completed
Location
Research Facility
Start Date
2017-09-07
Trial ID
NCT02963831
Treatments Being Tested